Federated Hermes
TIL icon

Federated Hermes’s Instil Bio TIL Stock Holding History

Federated Hermes’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-442
Closed -$43K – 2285
2022
Q3 		$43K Buy
+442
New +$50.6K ﹤0.01% 1691

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's TIL Position: Q4 2022 in Review

Federated Hermes sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 442 shares — an estimated $43K sold.

Federated Hermes first reported a position in TIL in Q3 2022 and held it in 1 quarter. The position peaked at $43K in Q3 2022. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Federated Hermes reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 442 Instil Bio shares in Q4 2022, an estimated $43K.
  • Federated Hermes first reported a position in Instil Bio in Q3 2022 and held it in 1 quarter.
  • Federated Hermes's Instil Bio position peaked at $43K in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.